Search

IQVIA Holdings Inc

Открыт

СекторЗдравоохранение

265.7 -1.41

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

265.66

Макс.

271.67

Ключевые показатели

By Trading Economics

Доход

-17M

258M

Продажи

217M

4.4B

P/E

Средняя по отрасли

33.616

56.432

Прибыль на акцию

2.75

Рентабельность продаж

5.907

Сотрудники

94,000

EBITDA

-18M

790M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+2.28% upside

Дивиденды

By Acuity

Следующий отчет о доходах

27 окт. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

9B

45B

Предыдущая цена открытия

267.11

Предыдущая цена закрытия

265.7

Новостные настроения

By Acuity

50%

50%

125 / 339 Рейтинг в Healthcare

IQVIA Holdings Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

16 сент. 2026 г., 19:36 UTC

IQVIA Holdings Inc shares fell, pulling back from earlier gains, and are currently lower since Tuesday's close while remaining above the 20-day moving average.

15 сент. 2026 г., 23:01 UTC

IQVIA Holdings Inc. shares are higher in after-market trading, reflecting a broader market uptick amid no specific company news. The stock remains above its 20-day moving average.

14 сент. 2026 г., 23:26 UTC

IQVIA Holdings Inc. shares are lower in after-market trading, reflecting broader market dynamics amid concerns over rising crude oil prices and inflation expectations.

11 сент. 2026 г., 20:13 UTC

IQVIA Holdings Inc. shares are trading higher in after-market hours, despite no specific news driving the movement. Inflation data has fueled interest rate hike speculation.

10 сент. 2026 г., 20:07 UTC

News

IQVIA Holdings priced a $2 billion senior notes offering to redeem debt. The Arizona State Retirement System raised its stake by 5.1%.

9 сент. 2026 г., 19:56 UTC

Correlated Moves
News

IQVIA Holdings plans to raise $2 billion through senior notes. Shares are lower amid concerns over leverage and market conditions affecting financial stability.

8 сент. 2026 г., 21:01 UTC

IQVIA Holdings Inc. shares are higher in after-market trading, advancing since Tuesday's close and remaining above their 20-day moving average.

4 сент. 2026 г., 20:07 UTC

IQVIA Holdings Inc is lower in Friday's session, reflecting broader market trends. The stock remains above its 20-day moving average despite the decline.

3 сент. 2026 г., 22:51 UTC

News

IQVIA Holdings launched its Predictive Clinical Development platform, aimed at enhancing clinical trial efficiency, but shares are trading lower in after-market hours.

2 сент. 2026 г., 23:51 UTC

IQVIA Holdings Inc shares rose in after-market trading, continuing upward momentum amid a broader macroeconomic backdrop following the ADP payrolls report.

1 сент. 2026 г., 19:36 UTC

Correlated Moves
News

IQVIA Holdings is trading lower today, influenced by Repligen Corp's decline and ongoing challenges in the life sciences sector.

31 авг. 2026 г., 23:46 UTC

News

IQVIA Holdings Inc shares are higher in after-market trading, remaining above their 20-day moving average amid sector growth expectations despite ongoing challenges.

28 авг. 2026 г., 19:36 UTC

News

IQVIA Holdings Inc. raised its 2026 guidance after reporting earnings growth, but shares are trading lower during Friday's session.

27 авг. 2026 г., 23:01 UTC

Shares of IQVIA Holdings Inc. are trading higher in after-market hours, remaining above the 20-day moving average and near the upper end of its one-month range.

26 авг. 2026 г., 23:21 UTC

Shares of IQVIA Holdings Inc. are lower in after-market trading, declining from earlier gains despite remaining above their 20-day moving average.

25 авг. 2026 г., 23:12 UTC

IQVIA Holdings Inc shares are lower in after-market trading. The decline occurs despite broader market gains following a drop in crude oil prices.

24 авг. 2026 г., 19:26 UTC

News
Correlated Moves

IQVIA Holdings Inc is trading roughly flat amid broader market dynamics, with Agilent Technologies Inc declining, suggesting potential influence on sentiment.

21 авг. 2026 г., 23:27 UTC

IQVIA Holdings Inc. shares advanced slightly higher in after-market trading, recovering from an earlier dip as traders engage in bargain hunting.

20 авг. 2026 г., 20:02 UTC

IQVIA Holdings Inc is trading higher today, maintaining strength despite broader market pressures. The stock remains above its 20-day moving average.

19 авг. 2026 г., 21:01 UTC

IQVIA Holdings Inc is higher in after-hours trading, advancing since Wednesday's close and trading near the upper end of its one-month range.

17 авг. 2026 г., 20:06 UTC

IQVIA Holdings Inc. shares are higher today, maintaining a strong performance above the 20-day moving average and near the top of its one-month trading range.

14 авг. 2026 г., 19:46 UTC

IQVIA Holdings Inc. shares are lower today, reflecting broader market trends following disappointing U.S. retail sales data for July. No specific company news was identified.

13 авг. 2026 г., 22:01 UTC

IQVIA Holdings Inc. shares are lower in after-market trading, despite broader market gains and a record close for the S&P 500.

12 авг. 2026 г., 19:46 UTC

News

IQVIA Holdings reported $3.2 billion in new bookings for Q2 2026, but shares are trading lower despite strong growth metrics.

11 авг. 2026 г., 22:46 UTC

IQVIA Holdings Inc shares are trading higher in after-market hours, showing strength despite a broader market decline influenced by rising crude oil prices.

10 авг. 2026 г., 23:01 UTC

IQVIA Holdings Inc is trading higher in after-market hours, maintaining a steady upward trajectory and positioning above its 20-day moving average.

8 авг. 2026 г., 00:01 UTC

IQVIA Holdings Inc shares are lower in after-market hours amid broader market concerns over Federal Reserve interest rate policies and a recent weak jobs report.

7 авг. 2026 г., 23:01 UTC

IQVIA Holdings Inc shares are lower in after-market hours, continuing a decline since Friday's close with no specific news identified for the drop.

6 авг. 2026 г., 20:06 UTC

IQVIA Holdings Inc shares are declining today, breaking a trend of higher closes since Wednesday. No specific news was identified to explain this movement.

5 авг. 2026 г., 20:03 UTC

Correlated Moves
News

IQVIA Holdings announced a collaboration with Medera to advance cardiac gene therapies. Positive sentiment from this partnership likely supported shares trading higher today.

Сравнение c конкурентами

Изменение цены

IQVIA Holdings Inc Прогноз

Целевая цена

By TipRanks

2.28% рост

Прогноз на 12 месяцев

Средняя 275.571 USD  2.28%

Максимум 300 USD

Минимум 240 USD

Основано на мнении 15 аналитиков Wall Street, спрогнозировавших целевые цены для IQVIA Holdings Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

15 ratings

14

Покупка

1

Удержание

0

Продажа

Настроения

By Acuity

125 / 339Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.